(RLJ) RLJ Lodging Trust - Overview
Stock: Hotels, Urban, Premium, Rooms, REIT
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 8.05% |
| Yield on Cost 5y | 5.03% |
| Yield CAGR 5y | 96.80% |
| Payout Consistency | 92.4% |
| Payout Ratio | 9.2% |
| Risk 5d forecast | |
|---|---|
| Volatility | 27.1% |
| Relative Tail Risk | -6.64% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.32 |
| Alpha | -28.96 |
| Character TTM | |
|---|---|
| Beta | 1.210 |
| Beta Downside | 1.265 |
| Drawdowns 3y | |
|---|---|
| Max DD | 44.24% |
| CAGR/Max DD | -0.21 |
Description: RLJ RLJ Lodging Trust January 20, 2026
RLJ Lodging Trust (NYSE: RLJ) is a self-advised REIT that owns 94 premium-branded, rooms-oriented hotels focused on high-margin, urban-centric properties located in the core of demand-rich markets across the United States. The portfolio is diversified geographically but concentrated in major cities that attract business, leisure, and mixed-purpose travelers.
Key operational metrics (as of the latest quarterly filing) show an average occupancy of roughly 71% and a RevPAR (Revenue per Available Room) of $84, reflecting modest recovery from pandemic lows but still trailing the pre-COVID peak of $112. The REIT’s weighted average daily rate (ADR) has risen about 4% YoY, driven by inflation-adjusted pricing and a shift toward higher-priced brand affiliations. Capital structure remains leveraged, with a net debt-to-EBITDA ratio near 5.5×, making the trust sensitive to rising interest rates-a sector-wide risk given the Federal Reserve’s tightening cycle.
Macro-level drivers include the rebound in corporate travel, which historically accounts for ~45% of urban hotel demand, and the ongoing shortage of new hotel supply in core metros, which supports pricing power. Conversely, any sustained slowdown in discretionary travel or a further increase in financing costs could compress margins.
For a deeper quantitative breakdown of RLJ’s valuation metrics, the ValueRay platform offers a concise, data-driven dashboard worth reviewing.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 33.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 1.25 > 1.0 |
| NWC/Revenue: 16.69% < 20% (prev 15.94%; Δ 0.75% < -1%) |
| CFO/TA 0.05 > 3% & CFO 251.9m > Net Income 33.5m |
| Net Debt (1.97b) to EBITDA (328.5m): 5.98 < 3 |
| Current Ratio: 1.92 > 1.5 & < 3 |
| Outstanding Shares: last quarter (149.1m) vs 12m ago -2.68% < -2% |
| Gross Margin: 26.79% > 18% (prev 0.28%; Δ 2651 % > 0.5%) |
| Asset Turnover: 27.92% > 50% (prev 27.81%; Δ 0.11% > 0%) |
| Interest Coverage Ratio: 1.31 > 6 (EBITDA TTM 328.5m / Interest Expense TTM 106.4m) |
Altman Z'' -0.74
| A: 0.05 (Total Current Assets 470.2m - Total Current Liabilities 244.6m) / Total Assets 4.79b |
| B: -0.24 (Retained Earnings -1.15b / Total Assets 4.79b) |
| C: 0.03 (EBIT TTM 139.5m / Avg Total Assets 4.84b) |
| D: -0.44 (Book Value of Equity -1.15b / Total Liabilities 2.59b) |
| Altman-Z'' Score: -0.74 = B |
Beneish M -2.90
| DSRI: 1.16 (Receivables 30.4m/26.4m, Revenue 1.35b/1.36b) |
| GMI: 1.06 (GM 26.79% / 28.27%) |
| AQI: 0.99 (AQ_t 0.88 / AQ_t-1 0.88) |
| SGI: 0.99 (Revenue 1.35b / 1.36b) |
| TATA: -0.05 (NI 33.5m - CFO 251.9m) / TA 4.79b) |
| Beneish M-Score: -2.90 (Cap -4..+1) = A |
What is the price of RLJ shares?
Over the past week, the price has changed by +3.33%, over one month by +2.11%, over three months by +15.22% and over the past year by -12.88%.
Is RLJ a buy, sell or hold?
- StrongBuy: 3
- Buy: 0
- Hold: 5
- Sell: 1
- StrongSell: 1
What are the forecasts/targets for the RLJ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 8.4 | 8.8% |
| Analysts Target Price | 8.4 | 8.8% |
| ValueRay Target Price | 9 | 16.6% |
RLJ Fundamental Data Overview February 03, 2026
P/E Forward = 144.9275
P/S = 0.8351
P/B = 0.62
P/EG = 1.41
Revenue TTM = 1.35b USD
EBIT TTM = 139.5m USD
EBITDA TTM = 328.5m USD
Long Term Debt = 2.22b USD (from longTermDebt, last quarter)
Short Term Debt = 725.2m USD (from shortTermDebt, last quarter)
Debt = 2.34b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.97b USD (from netDebt column, last quarter)
Enterprise Value = 3.09b USD (1.13b + Debt 2.34b - CCE 374.8m)
Interest Coverage Ratio = 1.31 (Ebit TTM 139.5m / Interest Expense TTM 106.4m)
EV/FCF = 13.90x (Enterprise Value 3.09b / FCF TTM 222.5m)
FCF Yield = 7.19% (FCF TTM 222.5m / Enterprise Value 3.09b)
FCF Margin = 16.47% (FCF TTM 222.5m / Revenue TTM 1.35b)
Net Margin = 2.48% (Net Income TTM 33.5m / Revenue TTM 1.35b)
Gross Margin = 26.79% ((Revenue TTM 1.35b - Cost of Revenue TTM 989.2m) / Revenue TTM)
Gross Margin QoQ = 24.25% (prev 30.43%)
Tobins Q-Ratio = 0.65 (Enterprise Value 3.09b / Total Assets 4.79b)
Interest Expense / Debt = 1.21% (Interest Expense 28.3m / Debt 2.34b)
Taxrate = 2.29% (1.60m / 69.8m)
NOPAT = 136.3m (EBIT 139.5m * (1 - 2.29%))
Current Ratio = 1.92 (Total Current Assets 470.2m / Total Current Liabilities 244.6m)
Debt / Equity = 1.07 (Debt 2.34b / totalStockholderEquity, last quarter 2.19b)
Debt / EBITDA = 5.98 (Net Debt 1.97b / EBITDA 328.5m)
Debt / FCF = 8.83 (Net Debt 1.97b / FCF TTM 222.5m)
Total Stockholder Equity = 2.24b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.69% (Net Income 33.5m / Total Assets 4.79b)
RoE = 1.50% (Net Income TTM 33.5m / Total Stockholder Equity 2.24b)
RoCE = 3.13% (EBIT 139.5m / Capital Employed (Equity 2.24b + L.T.Debt 2.22b))
RoIC = 3.33% (NOPAT 136.3m / Invested Capital 4.09b)
WACC = 4.17% (E(1.13b)/V(3.47b) * Re(10.37%) + D(2.34b)/V(3.47b) * Rd(1.21%) * (1-Tc(0.02)))
Discount Rate = 10.37% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.72%
[DCF Debug] Terminal Value 87.51% ; FCFF base≈199.9m ; Y1≈226.9m ; Y5≈309.8m
Fair Price DCF = 47.33 (EV 9.12b - Net Debt 1.97b = Equity 7.15b / Shares 151.1m; r=5.90% [WACC]; 5y FCF grow 15.79% → 2.90% )
EPS Correlation: -22.00 | EPS CAGR: 121.0% | SUE: 1.52 | # QB: 1
Revenue Correlation: 66.94 | Revenue CAGR: 9.10% | SUE: 1.94 | # QB: 1
EPS next Quarter (2026-03-31): EPS=-0.06 | Chg30d=-0.007 | Revisions Net=-1 | Analysts=3
EPS next Year (2026-12-31): EPS=-0.01 | Chg30d=-0.015 | Revisions Net=+0 | Growth EPS=-30.0% | Growth Revenue=+2.4%